The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Identification of functional genetic components modulating toxicity response to PFOS using genome-wide CRISPR screens in HepG2/C3A cells
Open accessPublished version of a preprint
Abstract
Perfluorooctane sulfonate (PFOS) poses significant health and environmental risks due to its persistence and widespread use and has been linked to various adverse outcomes, such as liver toxicity. Although the molecular responses and toxicity effects of PFOS exposure have been extensively studied, considerable uncertainty remains regarding the causal mechanisms leading to PFOS-associated adverse effects. To help bridge this gap, we conducted CRISPR screens in HepG2/C3A human liver cells exposed to IC 25 (170 µM) of PFOS to identify genes and pathways influencing PFOS-induced cytotoxicity. Using a genome-wide CRISPR knockout library targeting 18,819 genes, we identified 340 candidate genes that modulate PFOS-induced cytotoxicity when genetically disrupted (189 gene disruptions increased sensitivity and 151 gene disruptions increased resistance). From these candidate genes, we individually disrupted two candidate genes, SLC6A9 which encodes the glycine transporter GlyT1, and CPSF2 , and confirmed increased resistance to PFOS exposure. Further, molecular docking analysis predicts that PFOS directly binds to GlyT1 and functional inhibition of GlyT1 also increases resistance to PFOS exposure. Gene-Disease outcome association analysis using the Comparative Toxicogenomics Database (CTD) indicated an enrichment of candidate genes associated with cancer-related and liver disease phenotypes. KEGG and STRING enrichment analyses found over representation of several biological pathways including DNA damage response and cell cycle. Lastly, cross-species conservation analysis using the top two validated gene targets found that their pathways were highly conserved in several environmentally relevant species. These findings provide new mechanistic and functional insights into PFOS-induced cytotoxicity, highlight potential molecular targets for toxicity mitigation, and establish a foundation for cross-species toxicogenomic modeling of PFOS health effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Varadi, M., Bertoni, D., Magana, P., Paramval, U., Pidruchna, I., Radhakrishnan, M., Tsenkov, M., Nair, S., Mirdita, M., Yeo, J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1011 · Cited by 2,052
Costello, E., Rock, S., Stratakis, N., Eckel, S. P., Walker, D. I., Valvi, D., Cserbik, D., Jenkins, T., Xanthakos, S. A., Kohli, R., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10092 · Cited by 420
Carcinogenicity of Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid
Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., Blystone, C. R., Calkins, M. M., Dong, G.-H., Dorman, D. C., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00622-8 · Cited by 387
Cui, L., Zhou, Q.-F., Liao, C.-Y., Fu, J.-J., & Jiang, G.-B. (2009) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-008-9194-6 · Cited by 368
Evans, N., Conley, J. M., Cardon, M., Hartig, P., Medlock-Kakaley, E., & Gray, L. E. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116136 · Cited by 208
Winquist, A., Hodge, J. M., Diver, W. R., Rodriguez, J. L., Troeschel, A. N., Daniel, J., & Teras, L. R. (2023) · Environmental Health Perspectives · doi:10.1289/ehp13174 · Cited by 75
Flagged first, then by citations
Research works printed but not linked: 73
- Addicks GC, Rowan-Carroll A, Reardon AJF et al (2023) Per- and polyfluoroalkyl substances (PFAS) in mixtures show additive effects on transcriptomic points of departure in human liver spheroids. Toxicol Sci 194:38–52. https://doi.org/10.1093/toxsci/kfad044 · DOI
- Atkinson BN, Bell SC, De Vivo M et al (2001) ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Mol Pharmacol 60:1414–1420. https://doi.org/10.1124/mol.60.6.1414 · DOI
- Azhagiya Singam ER, Durkin KA, Merrill L, M. A. et al (2024) Prediction of the interactions of a large number of per- and poly-fluoroalkyl substances with ten nuclear receptors. Environ Sci Technol 58:4487–4499. https://doi.org/10.1021/acs.est.3c05974 · DOI
- Beale DJ, Sinclair GM, Shah R et al (2022) A review of omics-based PFAS exposure studies reveals common biochemical response pathways. Sci Total Environ 845:157255. https://doi.org/10.1016/j.scitotenv.2022.157255 · DOI
- Bessone F, Poles N, Roma MG (2014) Challenge of liver disease in systemic lupus erythematosus: clues for diagnosis and hints for pathogenesis. World J Hepatol 6:394–409. https://doi.org/10.4254/wjh.v6.i6.394 · DOI
- Bjork JA, Butenhoff JL, Wallace KB (2011) Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology 288:8–17. https://doi.org/10.1016/j.tox.2011.06.012 · DOI
- Borghese MM, Liang CL, Owen J et al (2022) Individual and mixture associations of perfluoroalkyl substances on liver function biomarkers in the Canadian Health Measures Survey. Environ Health 21:85. https://doi.org/10.1186/s12940-022-00892-6 · DOI
- Butenhoff JL, Chang S-C, Olsen GW et al (2012) Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology 293:1–15. https://doi.org/10.1016/j.tox.2012.01.003 · DOI
- Buttke DE (2011) Toxicology, environmental health, and the one health concept. J Med Toxicol 7:329–332. https://doi.org/10.1007/s13181-011-0172-4 · DOI
- Cheng X, Wei Y, Zhang Z, et al et al (2022) Plasma PFOA and PFOS levels, DNA methylation, and blood lipid levels: a pilot study. Environ Sci Technol 56:17039–17051. https://doi.org/10.1021/acs.est.2c04107 · DOI
- Cui R, Zhang H, Guo X et al (2015) Proteomic analysis of cell proliferation in a human hepatic cell line (HL-7702) induced by perfluorooctane sulfonate using iTRAQ. J Hazard Mater 299:361–370. https://doi.org/10.1016/j.jhazmat.2015.06.031 · DOI
- Davidsen N, Ramhøj L, Kugathas I et al (2022) PFOS disrupts key developmental pathways during hiPSC-derived cardiomyocyte differentiation in vitro. Toxicol Vitro 85:105475. https://doi.org/10.1016/j.tiv.2022.105475 · DOI
- Davis AP, Wiegers TC, Sciaky D et al (2025) Comparative toxicogenomics database’s 20th anniversary: update 2025. Nucleic Acids Res 53:D1328–D1334. https://doi.org/10.1093/nar/gkae883 · DOI
- de Carvalho GA, Tambwe PM, Nascimento LRC et al (2024) In silico evidence of bitopertin’s broad interactions within the SLC6 transporter family. J Pharm Pharmacol 76:1199–1211. https://doi.org/10.1093/jpp/rgae051 · DOI
- Deng P, Durham J, Liu J et al (2022) Metabolomic, lipidomic, transcriptomic, and metagenomic analyses in mice exposed to PFOS and fed soluble and insoluble dietary fibers. Environ Health Perspect 130:117003. https://doi.org/10.1289/EHP11360 · DOI
- Dominski Z, Tong L (2021) U7 deciphered: the mechanism that forms the unusual 3′ end of metazoan replication-dependent histone mRNAs. Biochem Soc Trans 49:2229–2240. https://doi.org/10.1042/BST20210323 · DOI
- Drury NL, Prueitt RL, Beck BD (2024) Commentary: Understanding IARC’s PFOA and PFOS carcinogenicity assessments. Regul Toxicol Pharmacol 154:105726. https://doi.org/10.1016/j.yrtph.2024.105726 · DOI
- Ehrlich V, Bil W, Vandebriel R et al (2023) Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS). Environ Health 22:19. https://doi.org/10.1186/s12940-022-00958-5 · DOI
- Ekuban FA, Gripshover TC, Ames P et al (2025) Perfluorooctane sulfonate exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model. Toxicol Sci. https://doi.org/10.1093/toxsci/kfaf066 · DOI
- Eldridge CB, Allen FJ, Crisp A et al (2020) A p53-dependent checkpoint induced upon DNA damage alters cell fate during HiPSC differentiation. Stem Cell Rep 15:827–835. https://doi.org/10.1016/j.stemcr.2020.08.003 · DOI
- Fenton SE, Ducatman A, Boobis A et al (2021) Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem 40:606–630. https://doi.org/10.1002/etc.4890 · DOI · Paper page
- George B, You D, Joy MS et al (2017) Xenobiotic transporters and kidney injury. Adv Drug Deliv Rev 116:73–91. https://doi.org/10.1016/j.addr.2017.01.005 · DOI
- Göckener B, Weber T, Rüdel H et al (2020) Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019. Environ Int 145:106123. https://doi.org/10.1016/j.envint.2020.106123 · DOI · Paper page
- Gonçalves E, Thomas M, Behan FM et al (2021) Minimal genome-wide human CRISPR-Cas9 library. Genome Biol 22:40. https://doi.org/10.1186/s13059-021-02268-4 · DOI
- Howard A, Tahir I, Javed S et al (2010) Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage. J Physiol 588:995–1009. https://doi.org/10.1113/jphysiol.2009.186262 · DOI
- India-Aldana S, Yao M, Midya V et al (2023) PFAS exposures and the human metabolome: a systematic review of epidemiological studies. Curr Pollution Rep. https://doi.org/10.1007/s40726-023-00269-4 · DOI · Paper page
- Jane L, Espartero L, Yamada M, Ford J et al (2022) Health-related toxicity of emerging per- and polyfluoroalkyl substances: comparison to legacy PFOS and PFOA. Environ Res 212:113431. https://doi.org/10.1016/j.envres.2022.113431 · DOI
- Jiajing C, Shuqi Y, Haoyan M et al (2024) Perfluorooctane sulfonate causes damage to L-02 cells via Wnt/β-catenin signal path and Endoplasmic reticulum stress pathway. Toxicol Ind Health 40:653–666. https://doi.org/10.1177/07482337241277259 · DOI
- Joung J, Konermann S, Gootenberg JS et al (2017) Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc 12:828–863. https://doi.org/10.1038/nprot.2017.016 · DOI · Paper page
- Kim S, Thapar I, Brooks BW (2021) Epigenetic changes by per- and polyfluoroalkyl substances (PFAS). Environ Pollut 279:116929. https://doi.org/10.1016/j.envpol.2021.116929 · DOI
- Klaassen CD (2002) Xenobiotic transporters: another protective mechanism for chemicals. Int J Toxicol 21:7–12. https://doi.org/10.1080/10915810252825975 · DOI
- Lee J-K, Lee S, Choi Y-A et al (2018) Perfluorooctane sulfonate exacerbates mast cell-mediated allergic inflammation by the release of Histamine. Mol Cell Toxicol 14:173–181. https://doi.org/10.1007/s13273-018-0019-z · DOI
- Li W, Xu H, Xiao T et al (2014) MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol 15:554. https://doi.org/10.1186/s13059-014-0554-4 · DOI · Paper page
- Li F, Yang R, Lu L et al (2024) Comparative steroidogenic effects of hexafluoropropylene oxide trimer acid (HFPO-TA) and perfluorooctanoic acid (PFOA): regulation of histone modifications. Environ Pollut 350:124030. https://doi.org/10.1016/j.envpol.2024.124030 · DOI
- Li H, Yu B, Yuan Y et al (2025) Integrated computational analysis of molecular mechanisms underlying perfluorooctane sulfonic acid induced thyroid toxicity. Sci Rep 15:7920. https://doi.org/10.1038/s41598-025-92678-2 · DOI
- Ling J, Hua L, Qin Y et al (2023) Perfluorooctane sulfonate promotes hepatic lipid accumulation and steatosis in high-fat diet mice through AMP-activated protein kinase/acetyl-CoA carboxylase (AMPK/ACC) pathway. J Appl Toxicol 43:312–322. https://doi.org/10.1002/jat.4383 · DOI
- Liu L, Manley JL (2024) Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3′ ends. RNA 30:1122–1140. https://doi.org/10.1261/rna.080108.124 · DOI
- Liu G, Zhang S, Yang K et al (2016) Toxicity of perfluorooctane sulfonate and perfluorooctanoic acid to Escherichia coli: membrane disruption, oxidative stress, and DNA damage induced cell inactivation and/or death. Environ Pollut 214:806–815. https://doi.org/10.1016/j.envpol.2016.04.089 · DOI
- Louisse J, Rijkers D, Stoopen G et al (2020) Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells. Arch Toxicol 94:3137–3155. https://doi.org/10.1007/s00204-020-02808-0 · DOI
- Louisse J, Fragki S, Rijkers D et al (2023) Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells. Arch Toxicol 97:1113–1131. https://doi.org/10.1007/s00204-023-03450-2 · DOI
- Louisse J, Pedroni L, van den Heuvel JJMW et al (2024) In vitro and in silico characterization of the transport of selected perfluoroalkyl carboxylic acids and perfluoroalkyl sulfonic acids by human organic anion transporter 1 (OAT1), OAT2 and OAT3. Toxicology 509:153961. https://doi.org/10.1016/j.tox.2024.153961 · DOI
- Mackay CR (2001) Chemokines: immunology’s high impact factors. Nat Immunol 2:95–101. https://doi.org/10.1038/84298 · DOI
- Marques E, Pfohl M, Auclair A et al (2020) Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice. Toxicol Appl Pharmcol 408:115250. https://doi.org/10.1016/j.taap.2020.115250 · DOI
- Mayes K, Qiu Z, Alhazmi A et al (2014) ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy. Adv Cancer Res 121:183–233. https://doi.org/10.1016/B978-0-12-800249-0.00005-6 · DOI
- O’Shea SH, Schwarz J, Kosyk O et al (2011) In vitro screening for population variability in chemical toxicity. Toxicol Sci 119:398–407. https://doi.org/10.1093/toxsci/kfq322 · DOI
- Otero-Sabio C, Giacomello M, Centelleghe C et al (2022) Cell cycle alterations due to perfluoroalkyl substances PFOS, PFOA, PFBS, PFBA and the new PFAS C6O4 on bottlenose Dolphin (Tursiops truncatus) skin cell. Ecotoxicol Environ Saf 244:113980. https://doi.org/10.1016/j.ecoenv.2022.113980 · DOI
- Owen R, de Macedo G, Nerlich J et al (2025) Perfluorooctanesulfonic acid (PFOS) antagonizes gamma-aminobutyric acid (GABA) receptors in larval zebrafish and mammalian models. Toxicol Sci 207:449–466. https://doi.org/10.1093/toxsci/kfaf101 · DOI
- Pérez F, Nadal M, Navarro-Ortega A et al (2013) Accumulation of perfluoroalkyl substances in human tissues. Environ Int 59:354–362. https://doi.org/10.1016/j.envint.2013.06.004 · DOI · Paper page
- Pfohl M, Marques E, Auclair A et al (2021) An omics approach to unraveling the Paradoxical effect of diet on perfluorooctanesulfonic acid (PFOS) and perfluorononanoic acid (PFNA)-induced hepatic steatosis. Toxicol Sci 180:277–294. https://doi.org/10.1093/toxsci/kfaa172 · DOI
- Rhee J, Chang VC, Cheng I et al (2023) Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the multiethnic cohort study. Environ Int 180:108197. https://doi.org/10.1016/j.envint.2023.108197 · DOI
- Rivetti C, Houghton J, Basili D et al (2023) Genes-to-pathways species conservation analysis: enabling the exploration of conservation of biological pathways and processes across species. Environ Toxicol Chem 42:1152–1166. https://doi.org/10.1002/etc.5600 · DOI
- Rockett JC (2002) Use of genomic data in risk assessment. Genome Biol 3:reports4011.1–reports4011.3 · DOI
- Rowan-Carroll A, Reardon A, Leingartner K et al (2021) High-Throughput transcriptomic analysis of human primary hepatocyte spheroids exposed to per- and polyfluoroalkyl substances as a platform for relative potency characterization. Toxicol Sci 181:199–214. https://doi.org/10.1093/toxsci/kfab039 · DOI
- Russo M, Sobh A, Zhang P et al (2020) Functional pathway identification with CRISPR/Cas9 Genome-wide gene disruption in human dopaminergic neuronal cells following chronic treatment with dieldrin. Toxicol Sci 176:366–381. https://doi.org/10.1093/toxsci/kfaa071 · DOI
- Salihovic S, Fall T, Ganna A et al (2019) Identification of metabolic profiles associated with human exposure to perfluoroalkyl substances. J Expo Sci Environ Epidemiol 29:196–205. https://doi.org/10.1038/s41370-018-0060-y · DOI
- Sauvé S (2024) Toxicology, environmental chemistry, ecotoxicology, and one health: definitions and paths for future research. Front Environ Sci. https://doi.org/10.3389/fenvs.2024.1303705 · DOI
- Schumann P, Rivetti C, Houghton J et al (2024) Combination of computational new approach methodologies for enhancing evidence of biological pathway conservation across species. Sci Total Environ 912:168573. https://doi.org/10.1016/j.scitotenv.2023.168573 · DOI
- Sobh A, Loguinov A, Stornetta A et al (2019) Genome-Wide CRISPR screening identifies the tumor suppressor candidate OVCA2 as a determinant of tolerance to acetaldehyde. Toxicol Sci 169:235–245. https://doi.org/10.1093/toxsci/kfz037 · DOI
- Sondka Z, Dhir NB, Carvalho-Silva D et al (2024) COSMIC: a curated database of somatic variants and clinical data for cancer. Nucleic Acids Res 52:D1210–D1217. https://doi.org/10.1093/nar/gkad986 · DOI
- Spahn PN, Bath T, Weiss RJ et al (2017) PinAPL-Py: a comprehensive web-application for the analysis of CRISPR/Cas9 screens. Sci Rep 7:15854. https://doi.org/10.1038/s41598-017-16193-9 · DOI
- Steenland K, Winquist A (2021) PFAS and cancer, a scoping review of the epidemiologic evidence. Environ Res 194:110690. https://doi.org/10.1016/j.envres.2020.110690 · DOI
- Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638–D646. https://doi.org/10.1093/nar/gkac1000 · DOI · Paper page
- Tang D, Chen M, Huang X et al (2023) SRplot: A free online platform for data visualization and graphing. PLoS ONE 18:e0294236. https://doi.org/10.1371/journal.pone.0294236 · DOI
- van Gerwen M, Colicino E, Guan H et al (2023) Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk. eBioMedicine. https://doi.org/10.1016/j.ebiom.2023.104831 · DOI
- Vujic E, Ferguson SS, Brouwer KLR (2024) Effects of PFAS on human liver transporters: implications for health outcomes. Toxicol Sci 200:213. https://doi.org/10.1093/toxsci/kfae061 · DOI
- Wang X, Wang J, Raza SHA et al (2022) Identification of the hub genes related to adipose tissue metabolism of bovine. Front Vet Sci. https://doi.org/10.3389/fvets.2022.1014286 · DOI
- Wee SY, Aris AZ (2023) Environmental impacts, exposure pathways, and health effects of PFOA and PFOS. Ecotoxicol Environ Saf 267:115663. https://doi.org/10.1016/j.ecoenv.2023.115663 · DOI
- Wei Y, Li R, Meng Y et al (2024) Transport mechanism and pharmacology of the human GlyT1. Cell 187:1719–1732. https://doi.org/10.1016/j.cell.2024.02.026 · DOI
- Xue L, Xu J, Xiao P et al (2025) Perfluorooctane sulfonate (PFOS) induced bone loss by inhibiting FoxO1-mediated defense against oxidative stress in osteoblast. Ecotoxicol Environ Saf 290:117524. https://doi.org/10.1016/j.ecoenv.2024.117524 · DOI
- Zeng Z, Song B, Xiao R et al (2019) Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies. Environ Int 126:598–610. https://doi.org/10.1016/j.envint.2019.03.002 · DOI
- Zhang Z, Wippo CJ, Wal M et al (2011) A packing mechanism for nucleosome organization reconstituted across a eukaryotic genome. Science 332:977–980. https://doi.org/10.1126/science.1200508 · DOI
- Zhang X, Zhao L, Ducatman A et al (2023) Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults. JHEP Rep 5:100694. https://doi.org/10.1016/j.jhepr.2023.100694 · DOI
- Zhao Y, Wei L, Tagmount A et al (2021) Applying genome-wide CRISPR to identify known and novel genes and pathways that modulate formaldehyde toxicity. Chemosphere 269:128701. https://doi.org/10.1016/j.chemosphere.2020.128701 · DOI
Metadata
- Authors
- Kim, C., Tagmount, A., Zhu, Z., Wilson, F., Li, D., Ostrov, D. A., Brad Barbazuk, W., Bacher, R., & Vulpe, C. D.
- Affiliations
- University of Florida (US)
- Corresponding author
- Kim, Chanhee
- Venue
- Archives of Toxicology
- Published
- 2026-01-27
- Volume
- 100
- Issue
- 4
- Pages
- 1391-1410
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC12724516
- OpenAlex
- W7125790313
- Cited by
- 1
- References
- 7
- Citations by year
- 2026: 1
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Archives of Toxicology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (R01ES033625)
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- PFOS, PFOS toxicity, hepatotoxicity, cytotoxicity, CRISPR knockout screen, SLC6A9, glycine transporter 1, glycine transporter, gene disruption, DNA damage response, cell cycle, cross-species conservation, toxicogenomics, liver cancer, perfluorinated compounds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review